University of Zambia School of Medicine

Next Avenue Names 10 "Influencers in Aging" in Honor of 10th Anniversary

Retrieved on: 
Tuesday, December 6, 2022
Housing, BYU Division of Continuing Education, Faculty, Stanford School, Yale Institute of International Studies, MD, Netflix, Maid, College of Continuing and Professional Studies, Doctor of Philosophy, Yale school, MarketWatch, David Pearson (social care administrator), Minisode1: Blue Hour, National Council, National Council on Aging, Next Avenue, College, Dartmouth College, University of Zambia School of Medicine, McDowell, Long-term care, Hallmark, Woman, The Dartmouth Institute for Health Policy and Clinical Practice, Policy, Geisel School of Medicine, PBS, Psychology, University, News, Public health, Twin Cities PBS, African Americans, Howard University, Health, The Way Home, Internet celebrity, Management, Ageing, Economics

SAINT PAUL, Minn., Dec. 6, 2022 /PRNewswire/ -- Next Avenue, the national news and community destination for older adults that is part of the PBS system, revealed its 2022 "Influencers in Aging."

Key Points: 
  • The 2022 "Influencers in Aging" list recognizes remarkable people bringing solutions, innovation, inspiration, and big thinking to the aging space.
  • "They are pushing for new policies, providing new representation, and giving access to information that is changing what it means to age and live an older life."
  • Sandra Edmonds Crewe, PhD: Social Work Professor and Dean at Howard University, focusing on assisted and affordable housing for older African Americans.
  • Christopher Gardner, PhD: The Rehnborg Farquhar Professor of Medicine at the Stanford School of Medicine, studying diet and health.

Home Health Lab Startup Bisu Collaborates With Polaris Dawn to Develop New Ways to Monitor Astronaut Health

Retrieved on: 
Thursday, December 1, 2022
Motion sickness, Bone loss, Starlink, Risk, Sport, Urine, Decompression sickness, Polaris, Weightlessness, Saliva, Dartmouth, Kennedy Space Center, Association of British HealthTech Industries, Ukactive, MD, Geisel School of Medicine, University of Zambia School of Medicine, SpaceX, Health, Research, Bisu, US Sports Camps, Kidney, Kennedy Space Center Launch Complex 39A, Muscle, NASA, Phosphorus, Dragon

As both space accessibility and long-duration human spaceflights increase, keeping crews healthy by providing personalized, targeted countermeasures will be essential.

Key Points: 
  • As both space accessibility and long-duration human spaceflights increase, keeping crews healthy by providing personalized, targeted countermeasures will be essential.
  • Bisu is a startup that helps people improve their health and fitness through lab-grade testing at home.
  • "We're delighted to be working with Polaris Dawn and Prof. Buckey on this pioneering research," says Daniel Maggs , co-founder & CEO at Bisu.
  • The lab has performed work on bone loss, decompression sickness, motion sickness, and psychological countermeasures for isolation and confinement.

Dayton Children's Hospital begins long-term engagement with VisiQuate to deliver advanced analytics solutions that integrate hospital and physician billing data

Retrieved on: 
Thursday, December 1, 2022
Magnet, Pediatrics, U.S. News & World Report, Hospital, Elective surgery, Anomaly, Organization, United, Partnership, Dayton Children's Hospital, University of Zambia School of Medicine, Air force, Healthcare Facilities Accreditation Program, Wright, Automation, Health, Velocity, News, ROSA, Health insurance, Medicine, Sales

SANTA ROSA, Calif., Dec. 1, 2022 /PRNewswire/ -- VisiQuate, Inc., the industry-leading provider of advanced analytics, intelligent workflow, results-driven services and AI-powered automation offerings to America's most respected healthcare providers, and Dayton Children's Hospital today announced a four-year agreement under which Dayton Children's will implement VisiQuate solutions designed to decrease claims denials, accelerate revenue and enable more equitable contractual arrangements with payers.

Key Points: 
  • Dayton Children's Hospital is a nationally ranked healthcare facility, with awards for physician engagement, magnet status, and a top-tier orthopedics division.
  • The hospital has begun implementing VisiQuate's Denials Management Analytics and Revenue Management Analytics solutions, both of which hospital leaders said should begin delivering value almost immediately.
  • But we realized because of data silos and reporting limitations, we would only be looking for the most obvious opportunities.
  • We deliver optimized enterprise outcomes through a unique combination of complex data curation, deep AI & ML, advanced analytics and intelligent process automation.

Andrea A. Hayes Dixon, M.D., FACS, FAAP Appointed First Black Woman Dean of Howard University’s College of Medicine

Retrieved on: 
Thursday, September 22, 2022
FACOG, University of California, San Francisco, Department, COVID-19, Woman, Molecular biology, University of Zambia School of Medicine, Sarcoma, Howard University, MD, Howard University College of Medicine, Hospital, Religion, College, Neoplasm, MD Anderson Cancer Center, Toronto hospital baby deaths, African, Degenerative disease, Partnership, Melanoma, Stomach, UNC, History, UT, District, MBA, University of North Carolina at Greensboro, Friends, Dartmouth College, Patient, Science, Surgical oncology, Association, Medicine, GLOBE, University, ST, FAAP, Adventist HealthCare, Geisel School of Medicine, Association of American Medical Colleges, FACS, Management, Dentistry, Mighty

WASHINGTON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Howard University President Wayne A. I. Frederick, M.D., MBA announced the appointment of Andrea A. Hayes Dixon, M.D., FACS, FAAP as the Howard University College of Medicine dean.

Key Points: 
  • WASHINGTON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Howard University President Wayne A. I. Frederick, M.D., MBA announced the appointment of Andrea A. Hayes Dixon, M.D., FACS, FAAP as the Howard University College of Medicine dean.
  • With the appointment, effective October 3, 2022, Hayes Dixon becomes the first Black woman to serve as dean of The Howard University College of Medicine.
  • She will succeed Hugh Mighty, MD, MBA, FACOG, who served as dean of the College of Medicine since 2015.
  • I am truly honored and humbled to lead the outstanding Howard University College of Medicine, said Hayes Dixon.

Qstream Wins Brandon Hall Group HCM Excellence Award for Developing Nursing Skills at Dartmouth Health

Retrieved on: 
Thursday, September 8, 2022
Nursing, Health, Diabetes, Other Education, Hospitals, Education, Training, Other Health, Partnership, Training, National Cancer Institute, CEO, Program, Research, National Cancer Registrars Association, Development, Talent, Dartmouth, HCM, Geisel School of Medicine, News, Inclusion, Learning, Diabetes, Science, Gold, U.S. News & World Report, Organization, Hospital, White River, Diversity, Nursing, Medicine, Dartmouth–Hitchcock Medical Center, Insulin, Health, Roswell Park Comprehensive Cancer Center, Hospice, Certification, Human capital, University of Zambia School of Medicine, Knowledge, Acqui-hiring, Efficiency, Leadership development, Human resource management, Gaps, Patient, Pharmaceutical industry, Creative industries, Risk management

Qstream was honored for its work with Dartmouth Health , New Hampshires only academic health system, which equipped nurses with the necessary knowledge to properly provide insulin to diabetic patients.

Key Points: 
  • Qstream was honored for its work with Dartmouth Health , New Hampshires only academic health system, which equipped nurses with the necessary knowledge to properly provide insulin to diabetic patients.
  • To improve diabetes management, Dartmouth Health partnered with Qstream to reinforce the current best practices around administering insulin to diabetic patients.
  • Dartmouth Health leveraged Qstream's unique software algorithm that employs the testing effect and spaced repetition to ensure concept mastery and promote long-term knowledge retention.
  • Dartmouth Health , New Hampshire's only academic health system and the state's largest private employer, serves patients across northern New England.

Satsuma Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Progress in STS101 Development Program

Retrieved on: 
Tuesday, August 9, 2022
U.S. Securities and Exchange Commission, Nausea, Accounting, GLOBE, Triangle Park (Quezon City), Clinical trial, Security (finance), Pain, Marketing, Patient, ASCEND, Dartmouth, Food, Terminology, Migraine, DHE, International Headache Society, Risk, NDA, MBS, Industry, Mayo Clinic College of Medicine and Science, University of Zambia School of Medicine, SAN, Safety, Nasdaq, Magic: The Gathering core sets, 1993–2007, CMC, Geisel School of Medicine, Guideline, COVID-19, Chemistry, Neurology, File, FDA, DC, MedStar Georgetown University Hospital, DRS, Achievement, Plasma, Company, IHS, Research, Dihydroergotamine, Freedom, Pharmaceutical industry, Dietary supplement, Medical device, Science, Cephalalgia

(Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine, today reported financial results for the second quarter of 2022 and summarized progress in its STS101 development program.

Key Points: 
  • (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine, today reported financial results for the second quarter of 2022 and summarized progress in its STS101 development program.
  • Satsuma is on track to report topline results from the SUMMIT trial in the fourth quarter of 2022.
  • In May 2022, Satsuma completed clinical and chemistry, manufacturing and controls (CMC) pre-NDA meetings with the FDA for STS101.
  • Research and development expenses were $12.5 million for the second quarter 2022, compared to $8.4 million for the same period of 2021.

US Fertility welcomes Amy Lee Harris, M.D., to the Shady Grove Fertility (SGF) physician team

Retrieved on: 
Wednesday, July 27, 2022
Association, Fertility, Diagnosis, Health, American Society for Reproductive Medicine, Air force, ACOG, Wright, Uterine fibroid, American Association, United, Fertilisation, SGF, Publication, Reproductive medicine, Patient, ASRM, Department, Ovarian reserve, University of Zambia School of Medicine, United States Congress, Society, Medical device, Birth control, Gynaecology

COLORADO SPRINGS, Colo.,  July 27, 2022 /PRNewswire-PRWeb/ -- US Fertility, the largest, physician-led, integrated network of top-tier fertility practices in the United States, welcomes Amy Lee Harris, M.D., to Shady Grove Fertility's (SGF) Colorado Springs, Colorado, location. Dr. Harris is now accepting new patient appointments.

Key Points: 
  • COLORADO SPRINGS, Colo., July 27, 2022 /PRNewswire-PRWeb/ -- US Fertility , the largest, physician-led, integrated network of top-tier fertility practices in the United States, welcomes Amy Lee Harris, M.D.
  • , to Shady Grove Fertility's (SGF) Colorado Springs, Colorado , location.
  • "I am honored to join the extraordinary SGF Colorado team that is dedicated to providing world-class fertility care," shares Dr. Harris.
  • Dr. Harris will provide comprehensive fertility services, including:
    fertility and ovarian reserve testing and diagnosis,

Medline expands strategic partnership with Dayton Children's Hospital

Retrieved on: 
Tuesday, June 7, 2022
Magnet, Pediatrics, Adult, Wright, U.S. News & World Report, Dayton Children's Hospital, News, Air force, Partnership, Elective surgery, Organization, Solution, University of Zambia School of Medicine, Hospital, Health, United, Department, Overalls, MEDLINE, Health insurance, Medicine

NORTHFIELD, Ill., June 7, 2022 /PRNewswire/ -- Medline has become the laboratory supplies prime vendor for Ohio-based Dayton Children's Hospital, entering a $10 million, multi-year partnership. The partnership also marks Medline's first pediatric hospital laboratory prime vendor agreement. As Dayton Children's exclusive medical and surgical supplies partner for more than eight years, Medline will now also provide an extensive portfolio of laboratory supplies and solutions for the acute care facility.

Key Points: 
  • NORTHFIELD, Ill., June 7, 2022 /PRNewswire/ -- Medline has become the laboratory supplies prime vendor for Ohio-based Dayton Children's Hospital , entering a $10 million, multi-year partnership.
  • The partnership also marks Medline's first pediatric hospital laboratory prime vendor agreement.
  • As Dayton Children's exclusive medical and surgical supplies partner for more than eight years, Medline will now also provide an extensive portfolio of laboratory supplies and solutions for the acute care facility.
  • During the height of the pandemic, Dayton Children's tapped Medline for new laboratory supply chain and product standardization solutions, focusing on inventory allocations and transparency across ordering, stocking and utilization of testing kits and other laboratory supplies.

New study validates predictive biomarkers in diabetic kidney disease, an important step in precision medicine.

Retrieved on: 
Tuesday, May 3, 2022
EGFR, Type 2 diabetes, ACCORD, Emeritus, Kidney disease, LDT, Biomarker, Kidney, Patient, Geisel School of Medicine, University of Zambia School of Medicine, Advanced glycation end-product, Diabetes Care, Risk, Glycated hemoglobin, Dartmouth, Precision medicine, Sex, CEO, Multimedia, Pharmaceutical industry, Diabetes

LEBANON, N.H., May 3, 2022 /PRNewswire/ -- Journey Biosciences, Inc. A new study recently published in the journal Diabetes Care continues to validate the role that specific biomarkers - advanced glycation endproducts (AGEs) - in predicting if a person with diabetes will develop kidney disease. This personalized assessment builds on the developing field of precision medicine in diabetes.

Key Points: 
  • This personalized assessment builds on the developing field of precision medicine in diabetes.
  • Journey Biosciences Founder and Chief Scientific Officer, Paul Beisswenger, is a lead author of the study.
  • The study used two large cohorts of patients with type 2 diabetes undergoing intensive glucose-lowering therapies over a significant period of time to determine if AGEs were predictive of diabetic kidney disease.
  • The investigators found that the primary endpoint of a 30%
    reduction in kidney function (eGFR) was significantly associated with a higher AGE score.

meQuilibrium Adds IBM Exec Jonathan Gelfand to Its Executive Team

Retrieved on: 
Thursday, November 18, 2021
Digest, IBM, Health, Olympic, CEO, Neuroscience, Hess Corporation, Workforce, AI, Willis Towers Watson, Mental health, University of Zambia School of Medicine, Finance, University of Kansas Health System St. Francis Campus, MBA, Robert Wood Johnson Medical School, University, Doctor of Philosophy, Rutgers Business School – Newark and New Brunswick, MPH, Dartmouth, National Science Foundation, SVP, Technology, Fortune 500, Behaviorism, Risk, Doctor of Psychology, Reader's Digest, Geisel School of Medicine, Culture, National Geographic, Organization, Science, Public health, Health Promotion International, Rutgers University, National Board for Certified Counselors, Content, Kaiser Permanente, Growth, Management

An employer wellbeing culture expert, Jonathan joins meQuilibrium from IBM Corporation where he served as Global Wellbeing and Health Promotion Manager, leading global mental health strategy and resilience efforts for over 250,000 IBM employees.

Key Points: 
  • An employer wellbeing culture expert, Jonathan joins meQuilibrium from IBM Corporation where he served as Global Wellbeing and Health Promotion Manager, leading global mental health strategy and resilience efforts for over 250,000 IBM employees.
  • Jonathan earned an MBA from Rutgers Business School and a Master of Public Health degree from Rutgers Robert Wood Johnson Medical School.
  • meQuilibrium also announced these additions to its leadership team:
    David Wright, PsyD, joins meQuilibrium as SVP, Healthcare Sales, focusing on payer and insurance markets.
  • meQuilibrium harnesses the science of resilience, AI, predictive analytics, biometrics and neuroscience to help businesses build workforce wellbeing and potential.